Literature DB >> 25550901

Down-regulation of hypoxia-inducible factor-1 suppresses malignant biological behavior of triple-negative breast cancer cells.

Fang Wang1, Miaomiao Chang2, Yonghong Shi1, Lili Jiang3, Jing Zhao1, Ling Hai1, Gaowa Sharen3, Hua Du1.   

Abstract

This study is to investigate the effect and mechanism of reduced hypoxia-inducible factor (HIF)-1a expression on malignant behavior of MDA-MB-231 cells. HIF-1α expression was interfered by siRNA. Western blot was used to detect protein expression of HIF-1α, active fragments of caspase 3 and vimentin. Cell count, flow cytometry and Hoechst staining were used to evaluate cell growth and apoptosis. Matrigel invasion and wound scratch assay were performed to measure the ability of cell invasion and migration. After MDA-MB-231 cells were transfected with HIF-1α-targeted siRNA, HIF-1α protein expression was successfully interrupted and cell growth was retarded. Compared with random siRNA group, reduced HIF-1α protein expression in HIF-1α-targeted siRNA group facilitated cell apoptosis but had no effect on cell cycle. In addition, cells treated with HIF-1α-targeted siRNA expressed active fragments of caspase 3 (17 and 12 kD) after serum starvation for 0 to 60 h. Caspase 3 activity assay further confirmed the above finding. Reduced HIF-1α expression impaired the migration and invasiveness with a reduction in the expression of vimentin and CK18 protein. Inhibition of HIF-1α protein synthesis or enhancement of its degradation reversed its malignant phenotypes and could probably be a potential means for the treatment of triple-negative breast cancer.

Entities:  

Keywords:  Hypoxia-inducible factor-1; epithelial mesenchymal transition; small-interfering RNA; triple-negative breast cancer

Year:  2014        PMID: 25550901      PMCID: PMC4276159     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  21 in total

1.  In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI-3K/Akt and MEK1/ERK pathways.

Authors:  Yong-Hong Shi; Yu-Xiang Wang; Lynne Bingle; Li-Hua Gong; Wan-Jie Heng; Yan Li; Wei-Gang Fang
Journal:  J Pathol       Date:  2005-03       Impact factor: 7.996

2.  Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension.

Authors:  B H Jiang; J Z Zheng; S W Leung; R Roe; G L Semenza
Journal:  J Biol Chem       Date:  1997-08-01       Impact factor: 5.157

3.  Expression of phosphorylated Ser70 of Bcl-2 correlates with malignancy in human colorectal neoplasms.

Authors:  Eisaku Kondo; Takayoshi Miyake; Masao Shibata; Toshikazu Kimura; Hiromi Iwagaki; Shin-Ichi Nakamura; Takehiro Tanaka; Nobuya Ohara; Koichi Ichimura; Takashi Oka; Hiroyuki Yanai; Futoshi Shibasaki; Tadashi Yoshino
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

4.  miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity.

Authors:  M-P Puisségur; N M Mazure; T Bertero; L Pradelli; S Grosso; K Robbe-Sermesant; T Maurin; K Lebrigand; B Cardinaud; V Hofman; S Fourre; V Magnone; J E Ricci; J Pouysségur; P Gounon; P Hofman; P Barbry; B Mari
Journal:  Cell Death Differ       Date:  2010-10-01       Impact factor: 15.828

5.  Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1.

Authors:  B H Jiang; E Rue; G L Wang; R Roe; G L Semenza
Journal:  J Biol Chem       Date:  1996-07-26       Impact factor: 5.157

6.  Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness.

Authors:  Claudia Bocca; Monica Ievolella; Riccardo Autelli; Manuela Motta; Luciano Mosso; Bruno Torchio; Francesca Bozzo; Stefania Cannito; Claudia Paternostro; Sebastiano Colombatto; Maurizio Parola; Antonella Miglietta
Journal:  Expert Opin Ther Targets       Date:  2013-12-11       Impact factor: 6.902

Review 7.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

8.  Suppressing the malignant phenotypes of glioma cells by lentiviral delivery of small hairpin RNA targeting hypoxia-inducible factor-1α.

Authors:  Chang Gui Dong; William K K Wu; Su Yin Feng; Jun Yu; Jun Fei Shao; Gui Mei He
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

9.  The hypoxia factor Hif-1α controls neural crest chemotaxis and epithelial to mesenchymal transition.

Authors:  Elias H Barriga; Patrick H Maxwell; Ariel E Reyes; Roberto Mayor
Journal:  J Cell Biol       Date:  2013-05-27       Impact factor: 10.539

10.  BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha.

Authors:  Jee-Youn Kim; Hyun-Jong Ahn; Jong-Hoon Ryu; Kyoungho Suk; Jae-Hoon Park
Journal:  J Exp Med       Date:  2003-12-29       Impact factor: 14.307

View more
  2 in total

1.  Antitumor effects of low-dose tipifarnib on the mTOR signaling pathway and reactive oxygen species production in HIF-1α-expressing gastric cancer cells.

Authors:  Noriyuki Egawa; Tomokazu Tanaka; Shohei Matsufuji; Kohei Yamada; Kotaro Ito; Hiroshi Kitagawa; Keiichiro Okuyama; Yoshihiko Kitajima; Hirokazu Noshiro
Journal:  FEBS Open Bio       Date:  2021-04-08       Impact factor: 2.693

Review 2.  Quadruple-negative breast cancer: novel implications for a new disease.

Authors:  Shristi Bhattarai; Geetanjali Saini; Keerthi Gogineni; Ritu Aneja
Journal:  Breast Cancer Res       Date:  2020-11-19       Impact factor: 8.408

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.